Amarantus BioScience Holdings, Inc. (OTCMKTS:AMBS) Sees Significant Growth in Short Interest

Amarantus BioScience Holdings, Inc. (OTCMKTS:AMBS) was the recipient of a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 62,200 shares, a growth of 230.9% from the December 15th total of 18,800 shares. Based on an average trading volume of 1,205,600 shares, the short-interest ratio is presently 0.1 days.

AMBS opened at $0.01 on Thursday. The stock’s fifty day simple moving average is $0.01. Amarantus BioScience has a 52 week low of $0.00 and a 52 week high of $0.02.

About Amarantus BioScience

Amarantus BioScience Holdings, Inc, a biopharmaceutical company, focuses on the development of diagnostic and therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology, and regenerative medicine. The company's diagnostic products in development include the lymphocyte proliferation (LymPro) test, a diagnostic blood test for Alzheimer's disease; and MSPrecise, a proprietary DNA sequencing assay for the identification of patients with multiple sclerosis.

See Also: What is a good rate of return for a mutual fund?